Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

227 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-30

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to characterise inspiratory flow parameters across 2 Easyhaler® (EH) inhaler versions and Diskus® inhaler in patients with asthma (including children, adults, and the elderly) and in patients with chronic obstructive pulmonary disease (COPD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHaler

NCT04147572

Healthy Volunteer COPD

COMPLETED NA

Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers

NCT00984906

Asthma Pulmonary Disease, Chronic Obstructive

COMPLETED NA

Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD

NCT03755544

Asthma Chronic Obstructive Pulmonary Disease

COMPLETED

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus

NCT01856621

Asthma

COMPLETED PHASE1

Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction

NCT01033669

Asthma Pulmonary Disease, Chronic Obstructive

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Easyhaler type A

Group Type OTHER

Easyhaler type A

Intervention Type DEVICE

Easyhaler type A inhaler, 3 consecutive inhalations

Easyhaler type B

Group Type OTHER

Easyhaler type B

Intervention Type DEVICE

Easyhaler type B inhaler, 3 consecutive inhalations

Diskus inhaler

Group Type OTHER

Diskus inhaler

Intervention Type DEVICE

Diskus inhaler, 3 consecutive inhalations

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Easyhaler type A

Easyhaler type A inhaler, 3 consecutive inhalations

Intervention Type DEVICE

Easyhaler type B

Easyhaler type B inhaler, 3 consecutive inhalations

Intervention Type DEVICE

Diskus inhaler

Diskus inhaler, 3 consecutive inhalations

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SF EH (D94-2SF) SF EH (D94-2SF-B) Inhaler for Seretide Diskus

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent (IC) obtained
* Documented diagnosis of asthma and/or COPD
* Age: 4 years and above

Exclusion Criteria

* Any severe chronic respiratory disease other than asthma or COPD
* Acute respiratory infection
* Any medical condition that in the opinion of the investigator would endanger the subject if he/she participates in the study

Minimum Eligible Age

4 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No